Blessme · Anti-Panic & Anxiolytics

Clonazepam MD Tablets - DELOTRIL (1 mg)

DELOTRIL-1 is a high-potency Clonazepam Mouth Dissolving Tablets IP 1 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Formulated with rapid-melt oral disintegration technology, DELOTRIL-1 provides swift sublingual dissolution and sustained symptom control for severe panic disorder, chronic agoraphobia, and refractory seizure conditions across India.

Fast-Melt MD Formulation
Schedule H Prescription
Pan-India Supply
DELOTRIL-1 Clonazepam MD Tablets IP 1 mg pack by Blessme - Dellwich Lifescience LLP
Product Specifications

About Clonazepam MD 1 mg
(DELOTRIL-1)

Detailed pharmaceutical specifications, active API monograph compliance, fast-melt characteristics, and packaging details for DELOTRIL-1.

Blessme · Anti-Panic / Anticonvulsants

Clonazepam MD 1 mg - DELOTRIL

Clonazepam Mouth Dissolving Tablets IP 1 mg (DELOTRIL-1) is a high-potency benzodiazepine oral formulation engineered to dissolve rapidly on the tongue without water. Provides robust control for moderate-to-severe panic disorder, acute anxiety crises, and seizure maintenance under expert medical supervision.

Fast Mouth-Dissolving Technology (No Water Needed)Potent 1 mg Clinical Strength for Severe Panic & AnxietyEffective Oral Anticonvulsant in Myoclonic & Absence SeizuresRapid Sublingual & Mucosal Absorption Strict Indian Pharmacopoeia Quality Standards
Product Brand Name
DELOTRIL-1
Active Pharmaceutical Ingredient
Clonazepam IP (1 mg)Verified IP
Dosage Formulation
Mouth Dissolving Tablet (MD / ODT)
Therapeutic Class
High-Potency Benzodiazepine / Anti-Panic / Anxiolytic / Anticonvulsant
Strength
1 mg per tablet
Standard Packaging
5x4x10 (200 Tablets) Blister Pack
Regulatory Category
Schedule H Prescription Drug
Marketing Division
Blessme · Neuro & Psychiatric Products
Marketing & Distribution Company
Dellwich Lifescience LLP, Ahmedabad, Gujarat
Storage Condition
Store protected from light and moisture at a temperature below 25°C
Quality Standard
Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
Country of Origin
India
Clinical & Commercial Monograph

Clonazepam MD Tablet 1 mg & DELOTRIL
Complete Medical & Supply Guide

Comprehensive clinical and commercial guide on Clonazepam Mouth Dissolving Tablets IP 1 mg, marketed as DELOTRIL-1 by Blessme (Dellwich Lifescience LLP). Features receptor neurochemistry, clinical indications, comparative dosing, and B2B pharmaceutical distribution across India.

What is Clonazepam MD Tablet 1 mg (DELOTRIL-1)?

Clonazepam MD tablet 1 mg is an intensified clinical strength of Clonazepam IP formulated in an advanced orally disintegrating matrix. When lower dosages fail to adequately suppress severe panic attacks or stabilize refractory seizures, the 1 mg formulation delivers the necessary therapeutic potency.

In emergency psychiatric practice, a patient experiencing severe panic paroxysms may struggle with swallowing conventional tablets. DELOTRIL-1 dissolves smoothly on the tongue within 30 seconds upon contact with saliva, initiating fast mucosal uptake and clinical tranquilization without liquid administration.

Clinical Uses & Indications of Clonazepam MD 1 mg

Clonazepam MD tablet uses for the 1 mg strength focus on complex, high-severity neurological and psychiatric conditions:

  • Severe Panic Disorder with Agoraphobia: Effective containment of debilitating panic attacks unresponsive to 0.5 mg dosing.
  • Refractory Generalized Anxiety Disorder: Potent daytime symptom suppression in severe, unmanageable chronic anxiety.
  • Epileptic Seizure Syndromes: Oral adjunctive treatment in myoclonic seizures, atonic seizures, absence seizures, and Lennox-Gastaut syndrome.
  • Acute Akathisia & Motor Agitation: Rapid-onset management of neuroleptic-induced motor restlessness.
  • Bipolar Mania Adjunct: Short-term adjunctive sedation under inpatient psychiatric supervision.

Neurochemical Mechanism of Action: Potent GABA_A Receptor Modulation

Clonazepam 1 mg acts as a high-potency positive allosteric modulator on the GABAA receptor complex in the central nervous system. By enhancing the binding of gamma-aminobutyric acid (GABA), it increases the opening frequency of chloride ion channels, causing significant hyperpolarization of neuronal membranes.

This mechanism suppresses paroxysmal electrical firing in the amygdaloid nuclei, cortical fear networks, and thalamocortical circuits. The Mouth Dissolving (MD) formulation allows a portion of the drug to be absorbed sublingually and buccally, facilitating rapid systemic entry and symptom relief during intense panic paroxysms.

Clinical Comparison Across the DELOTRIL Range

The DELOTRIL portfolio provides tiered therapeutic options for individual patient requirements:

  • DELOTRIL-0.25 (0.25 mg): Starting micro-dose for initial acclimatization, mild situational anxiety, and elderly patients.
  • DELOTRIL-0.5 (0.5 mg): Standard first-line maintenance dose for established panic disorder and generalized anxiety.
  • DELOTRIL-1 (1 mg): High-potency clinical dose for severe panic attacks, refractory anxiety, and epileptic seizure control.
  • DELOTRIL-2 (2 mg): Specialized high-threshold dosage for refractory epilepsy syndromes and severe acute psychiatric crises.

Dosage Guidelines & Administration Method

DELOTRIL-1 must be administered under strict medical supervision:

  • Administration: Place the tablet on the tongue until it dissolves completely in saliva, then swallow. No water is required.
  • Severe Panic Disorder: Usually 0.5 mg to 1 mg twice daily; dosage should be titrated progressively.
  • Epileptic Seizures: Dosage is individualized based on body weight, seizure frequency, and combination antiepileptic therapy.
  • Tapering Protocol: When discontinuing, reduce dosage gradually by 0.125 mg to 0.25 mg every 3 days under physician guidance.

Clonazepam MD Tablet Brands in India & Sourcing DELOTRIL

Among established brands in India (Clonafit, Zapiz, Epitril), DELOTRIL-1 by Blessme has earned clinical trust for its reliability and commercial value:

  • Fast Salivary Disintegration: Melts completely within 30 seconds with a pleasant oral feel.
  • Moisture-Resistant Blister Strips: Protects tablet hardness against ambient humidity and degradation.
  • Manufacturer-Direct Commercials: Competitive B2B rates and high profit margins for PCD franchise distributors.
  • Complete Regulatory Dossiers: Authenticated COA, MSDS, and stability records provided with every batch.

Side Effects, Precautions & Patient Safety

Essential clinical warnings for healthcare professionals and patients:

  • Expected Reactions: Pronounced drowsiness, motor ataxia, dizziness, and cognitive slowing.
  • Avoid Concurrent Depressants: Never combine with alcohol, opioids, or sedatives due to lethal respiratory suppression risks.
  • Dependence Risk: High potency increases the risk of physical and psychological dependence; duration must be restricted to clinical necessity.
  • Contraindications: Severe respiratory insufficiency, sleep apnoea, myasthenia gravis, and severe liver failure.

Critical Safety Warning - Schedule H Controlled Psychotropic Substance

Clonazepam 1 mg is a high-potency benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use requires careful clinical monitoring. DELOTRIL-1 is supplied strictly against a valid medical prescription from a registered medical practitioner.

Quality & Production

Pharmaceutical Quality Assurance & Compliance

DELOTRIL-1 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.

01 / FAST-MELT MATRIX

Sub-30 Second Disintegration

Engineered with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.

02 / HIGH-BARRIER FOIL

Moisture-Proof Blister Sealing

Encased in 5x4x10 protective blister cavities that insulate the hygroscopic fast-melt tablet from ambient atmospheric moisture, heat, and physical crumbling.

03 / ANALYTICAL TESTING

COA & Content Uniformity

Strict pharmacopoeial monograph assays confirm precise 1 mg Clonazepam IP content, rapid disintegration limits, and dissolution conformity batch after batch.

04 / PRODUCTION STANDARDS

WHO-GMP & Schedule M

Produced in state-of-the-art clean-room compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP) with automated environmental controls.

Clinical Profile & Precautions

Approved Indications & Regulatory Guidelines

As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.

Prescription-Only Schedule H Medication Notice

DELOTRIL-1 contains Clonazepam IP 1 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.

Clinical Indications Profile

Approved neurological and psychiatric indications for Clonazepam MD 1 mg (DELOTRIL-1):

  • Moderate-to-Severe Panic Disorder: Rapid containment of intense panic attacks and anticipatory fear.
  • Refractory Generalized Anxiety Disorder: Potent daytime symptom control in chronic, unmanageable anxiety.
  • Epileptic Seizure Management: Maintenance oral therapy for myoclonic, absence, and refractory seizures.
  • Severe Agoraphobia: Alleviation of severe panic-induced avoidance behaviors.
  • Akathisia & Motor Restlessness: Symptomatic control in drug-induced extrapyramidal restlessness.

Pharmacology & Clinical Precautions

Key pharmacokinetic parameters and patient monitoring guidelines:

  • Mechanism: High-affinity positive allosteric modulation of GABA_A chloride channel conductance.
  • Synergistic Depression: Severe respiratory risk if co-administered with alcohol, opioids, or sedatives.
  • Hepatic Clearance: Extensively metabolized in the liver to 7-amino-clonazepam; dose reduction is advised in hepatic dysfunction.
  • Pregnancy Category D: Potential risks of fetal harm; avoid during pregnancy and lactation unless strictly essential.
Manufacturing & Marketing
Dellwich Lifescience LLP
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience

Trusted Neuro & Psychiatric Pharmaceutical Manufacturer in Ahmedabad, Gujarat

Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-1 (Clonazepam MD Tablets IP 1 mg).

We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.

Commercial Partnerships

DELOTRIL-1 Supply &
Pharmaceutical Distribution

Whether you are seeking DELOTRIL-1 (Clonazepam MD Tablets IP 1 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.

Monopoly PCD Franchise

Secure exclusive district-level distribution rights for DELOTRIL-1 and the entire Blessme Neuro portfolio with promotional visual aids, doctor samples, and attractive trade margins.

Third-Party Manufacturing

Contract manufacturing solutions for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.

Hospital & Institutional Supply

Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.

Blessme · DELOTRIL-1

Why Choose DELOTRIL-1 (Clonazepam MD 1 mg)?

When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-1 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.

WHO-GMP Certified Purity

Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.

High-Barrier Blister Packaging

Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.

Pan-India Dispatch from Ahmedabad

Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.

Monopoly PCD Franchise Rights

Exclusive district-level franchise rights for DELOTRIL-1 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.

Comprehensive Regulatory Dossiers

Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.

Direct Manufacturer Support

Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.

Common Questions

Frequently Asked Questions about DELOTRIL-1

Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 1 mg.

What is Clonazepam MD tablet 1 mg and what is DELOTRIL-1?

Clonazepam MD tablet 1 mg (marketed under the brand name DELOTRIL-1 by Blessme division of Dellwich Lifescience LLP) is an advanced orally disintegrating benzodiazepine formulation. Each tablet contains Clonazepam IP 1 mg, designed to dissolve swiftly on the tongue without water for quick sublingual and pre-gastric absorption, effectively controlling severe panic attacks, debilitating anxiety, and convulsive disorders.

What are the primary clinical indications of Clonazepam MD 1 mg?

DELOTRIL-1 is clinically prescribed for: (1) moderate-to-severe panic disorder with agoraphobia unresponsive to lower doses; (2) severe generalized anxiety disorder (GAD) requiring potent daytime stabilization; (3) maintenance oral anticonvulsant therapy in myoclonic, absence, and refractory epilepsy syndromes; and (4) acute severe motor restlessness and akathisia under specialist psychiatric supervision.

How does the Mouth Dissolving (MD) technology benefit patients taking DELOTRIL-1?

Mouth Dissolving (MD) technology allows DELOTRIL-1 to melt completely on the tongue within 30 seconds upon contact with saliva. Patients experiencing intense panic paroxysms, choking sensations, or situational tremors can take the tablet immediately without needing water, providing rapid onset and superior patient compliance.

What is the difference between DELOTRIL-0.5 and DELOTRIL-1?

DELOTRIL-0.5 contains 0.5 mg Clonazepam IP, which is the standard starting and maintenance dose for typical panic disorder. DELOTRIL-1 contains 1 mg Clonazepam IP, prescribed when patients exhibit high tolerance, severe refractory panic symptoms, or when managing higher-threshold epileptic seizure syndromes.

How does Clonazepam 1 mg work in the central nervous system?

Clonazepam 1 mg binds selectively with high affinity to benzodiazepine recognition sites on post-synaptic GABA_A receptors in the limbic system, thalamus, and cortex. This allosterically enhances gamma-aminobutyric acid (GABA) inhibitory transmission, opening chloride channels and causing sustained hyperpolarization that suppresses overactive panic and seizure neural pathways.

Can DELOTRIL-1 be purchased over-the-counter without a prescription?

No. Clonazepam 1 mg is strictly categorized as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-1 is supplied exclusively against a valid prescription issued by a registered medical practitioner.

What packaging and strip configurations are available for DELOTRIL-1?

DELOTRIL-1 is packaged in premium 5x4x10 blister strips (200 tablets per box) manufactured with moisture-barrier foils that prevent ambient humidity from softening the sensitive fast-melt tablet matrix.

Who manufactures and markets DELOTRIL-1 in Ahmedabad, India?

DELOTRIL-1 is manufactured under WHO-GMP compliance and marketed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.

Is PCD pharma franchise available for DELOTRIL-1 across India?

Yes. Dellwich Lifescience LLP grants district-wise monopoly PCD pharma franchise opportunities for DELOTRIL-1 and the entire Blessme Neuro range, backed with visual aids, product cards, promotional inputs, and fast dispatch.

How should DELOTRIL-1 be administered and what is the recommended dosage?

Place the tablet directly on the tongue. Allow it to dissolve in saliva and swallow without water. For severe panic disorder, dosage is typically titrated from 0.5 mg up to 1 mg daily in divided doses. Dosage must strictly be adjusted and tapered under medical direction.

What are the common side effects of Clonazepam MD 1 mg tablet?

Common adverse effects include drowsiness, motor ataxia, fatigue, dizziness, and cognitive slowing. Patients must avoid driving motor vehicles or operating heavy machinery. Long-term use requires gradual dosage tapering to prevent withdrawal symptoms.

What is the price of Clonazepam 1 mg MD tablet in India?

DELOTRIL-1 provides cost-effective, high-quality healthcare with strong commercial margins. For trade price lists, PCD franchise terms, and institutional hospital supply quotes, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].

Does Dellwich Lifescience provide contract manufacturing for Clonazepam 1 mg MD tablets?

Yes. Dellwich Lifescience LLP provides third-party and contract manufacturing for Clonazepam MD tablets across all standard strengths (0.25 mg, 0.5 mg, 1 mg, 2 mg) in WHO-GMP certified facilities with complete stability validation.

Does DELOTRIL-1 come with an authenticated Certificate of Analysis (COA)?

Yes. Each batch of DELOTRIL-1 is accompanied by an authenticated Certificate of Analysis (COA), disintegration assay records, active IP testing, and Material Safety Data Sheet (MSDS).

Direct Pharmaceutical Enquiry

Need Verified Information or Bulk Supply of DELOTRIL-1?

Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.

Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs

Enquire About DELOTRIL-1

Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 1 mg.

🔒 Schedule H Drug notice: Product supplied strictly against valid drug licence and regulatory compliance.

Explore Further

Discover other specialized neuro-psychiatric treatments, PCD franchise categories, and hospital supply options from Dellwich Lifescience LLP.